ACE2 |
Angiotensin Converting Enzyme 2 |
Ala |
Alanine |
AMBER |
Assisted model building with energy refinement |
ANG II |
Angiotensin II |
AR1 |
Androgen receptor 1 |
ARBs |
Angiotensin II receptor blockers |
Arg |
Arginine |
AT1(2) |
ANG II receptors type 1 (2) |
Azil |
Azilsartan |
Bis |
Bisartan |
BPT |
Biphenyl tetrazole |
Cande |
Candesartan |
3CLpro |
3C-like protease |
COVID-19 |
Coronavirus diseases |
CRS |
Charge-relay system |
DIZE |
Deminazene aceturate |
DNA |
Deoxyribonucleic acid |
Epro |
Eprosartan |
EXP3174 |
Losartan carboxylic acid |
His |
Histidine |
ID |
Identifier |
Ile |
Isoleucine |
Irbe |
Irbesartan |
Leu |
Leucine |
Lo |
Losartan |
Lys |
Lysine |
MD |
Molecular dynamics |
mRNA |
Messenger ribonucleic acid |
NEP |
Neprilysin |
Olme |
Olmesartan |
PDB |
Protein Data Bank |
Phe |
Phenylalanine |
Pro |
Proline |
RAS |
Renin–angiotensin system |
RM1 |
Recife model 1 |
RMSD |
Root-mean-square-deviation |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Telmi |
Telmisartan |
TIP3P |
Transferable intermolecular potential with 3 points |
Trp |
Tryptophan |
Tyr |
Tyrosine |
UHF |
Unrestricted Hartree–Fock |
Val |
Valsartan |
YAMBER |
Yet Another Model Building and Energy Refinement |
YASARA |
Yet Another Scientific Artificial Reality Application |